Brooks Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2025 ,inter alia, to consider and approve the Audited standalone ....
BROOKS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Brooks Laboratories has informed BSE that its Board of Directors will meet on 28th May 2025 to consider and approve the audited standalone and consolidated financial results for the quarter and financial year ended 31st March 2025. The company has also confirmed that the trading window for its directors, designated persons, and their immediate relatives has been closed since 1st April 2025 and will reopen 48 hours after the results are declared. This is a routine regulatory filing under SEBI's Listing Obligations and Disclosure Requirements.
No direct impact on shareholders from this filing — it is a standard pre-result announcement. Investors should watch 28th May for the actual Q4 and FY25 numbers, which will provide insight into the company's full-year performance.